ATE375800T1 - Anti-hiv und anti-tumor lysozympeptide sowie fragmente - Google Patents
Anti-hiv und anti-tumor lysozympeptide sowie fragmenteInfo
- Publication number
- ATE375800T1 ATE375800T1 AT01957109T AT01957109T ATE375800T1 AT E375800 T1 ATE375800 T1 AT E375800T1 AT 01957109 T AT01957109 T AT 01957109T AT 01957109 T AT01957109 T AT 01957109T AT E375800 T1 ATE375800 T1 AT E375800T1
- Authority
- AT
- Austria
- Prior art keywords
- tumor
- fragment
- lysozympeptides
- hiv
- fragments
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title abstract 4
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- 230000036436 anti-hiv Effects 0.000 title 1
- 102000016943 Muramidase Human genes 0.000 abstract 2
- 108010014251 Muramidase Proteins 0.000 abstract 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract 2
- 235000010335 lysozyme Nutrition 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000922 anti-bactericidal effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960000274 lysozyme Drugs 0.000 abstract 1
- 239000004325 lysozyme Substances 0.000 abstract 1
- 229940051921 muramidase Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21670200P | 2000-07-07 | 2000-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE375800T1 true ATE375800T1 (de) | 2007-11-15 |
Family
ID=22808164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01957109T ATE375800T1 (de) | 2000-07-07 | 2001-07-09 | Anti-hiv und anti-tumor lysozympeptide sowie fragmente |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7838275B2 (de) |
| EP (1) | EP1303291B1 (de) |
| JP (1) | JP2004505616A (de) |
| AT (1) | ATE375800T1 (de) |
| AU (1) | AU2001278884A1 (de) |
| CA (1) | CA2415083A1 (de) |
| DE (1) | DE60130994T2 (de) |
| WO (1) | WO2002004011A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2472438A1 (en) * | 2002-06-28 | 2004-01-08 | Fuso Pharmaceutical Industries, Ltd. | Mannose binding protein for use in anti-hiv treatment |
| ITMI20061950A1 (it) * | 2006-10-11 | 2008-04-12 | Therapicon Srl | Effetto antimetastatico in condizioni patologiche delle cellule umane |
| EP2134354A4 (de) * | 2007-03-02 | 2012-03-21 | Saint Simeon Lda | Zusammensetzung und verfahren zur behandlung von papilloma-virus und pferde-sarcoiden |
| US20170049863A1 (en) * | 2014-02-21 | 2017-02-23 | National University Corporation Tokyo University Of Marine Science And Technology | Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes |
| JP6547915B2 (ja) | 2016-12-28 | 2019-07-24 | Dic株式会社 | 分散体及びそれを用いたインクジェット用インク組成物、光変換層、及び液晶表示素子 |
| CN110438106B (zh) * | 2019-08-06 | 2021-03-23 | 北京华韵国丰新材料科技有限公司 | 一种人工设计的纳米溶菌酶和纳米溶菌酶的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554501A (en) | 1992-10-29 | 1996-09-10 | Beckman Instruments, Inc. | Biopolymer synthesis using surface activated biaxially oriented polypropylene |
| US5583211A (en) * | 1992-10-29 | 1996-12-10 | Beckman Instruments, Inc. | Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides |
| JPH06211692A (ja) * | 1993-01-21 | 1994-08-02 | Nippon Oil Co Ltd | 免疫増強剤 |
| AU671688B2 (en) * | 1993-09-28 | 1996-09-05 | Beckman Instruments, Inc. | Biopolymer synthesis utilizing surface activated, organic polymers |
| AU3307497A (en) * | 1996-06-26 | 1998-01-14 | Antigen Express, Inc. | Immunotherapy by modulation of antigen presentation |
| WO1998026747A2 (en) | 1996-12-17 | 1998-06-25 | Terman David S | Superantigen based methods and compositions for treatment of diseases |
| GB9907366D0 (en) * | 1999-03-30 | 1999-05-26 | Medical Res Council | Method for expressing proteins |
-
2001
- 2001-07-09 AU AU2001278884A patent/AU2001278884A1/en not_active Abandoned
- 2001-07-09 CA CA002415083A patent/CA2415083A1/en not_active Abandoned
- 2001-07-09 EP EP01957109A patent/EP1303291B1/de not_active Expired - Lifetime
- 2001-07-09 JP JP2002508465A patent/JP2004505616A/ja active Pending
- 2001-07-09 AT AT01957109T patent/ATE375800T1/de not_active IP Right Cessation
- 2001-07-09 US US10/487,259 patent/US7838275B2/en not_active Expired - Fee Related
- 2001-07-09 DE DE60130994T patent/DE60130994T2/de not_active Expired - Lifetime
- 2001-07-09 WO PCT/US2001/021582 patent/WO2002004011A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60130994T2 (de) | 2008-07-24 |
| US20050008631A1 (en) | 2005-01-13 |
| EP1303291B1 (de) | 2007-10-17 |
| EP1303291A1 (de) | 2003-04-23 |
| DE60130994D1 (de) | 2007-11-29 |
| AU2001278884A1 (en) | 2002-01-21 |
| US7838275B2 (en) | 2010-11-23 |
| CA2415083A1 (en) | 2002-01-17 |
| WO2002004011A1 (en) | 2002-01-17 |
| EP1303291A4 (de) | 2005-04-06 |
| JP2004505616A (ja) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002100845A8 (en) | Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| WO2004071426A3 (en) | Compounds for the treatment of viral infection | |
| WO2004096818A3 (en) | Method and compositions for identifying anti-hiv therapeutic compounds | |
| BG100455A (en) | Hiv protease inhibitors | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| CA2473070A1 (en) | Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection | |
| NO20034204L (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
| NO974147D0 (no) | Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease | |
| DE69518840D1 (en) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
| ATE420099T1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| ATE375800T1 (de) | Anti-hiv und anti-tumor lysozympeptide sowie fragmente | |
| BR0112123A (pt) | Composto | |
| ATE370733T1 (de) | Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen | |
| DE60208541D1 (de) | Antibakterielle mittel | |
| WO2003049695A3 (en) | Compounds to treat hiv infection and aids | |
| BR9611520A (pt) | Composto hemo-reguladores. | |
| NO20024522L (no) | Sammensetninger med anti-hiv-aktivitet | |
| WO2002023784A3 (en) | Cysteine protease inhibitors | |
| ATE279195T1 (de) | Anthelminthika zur verhinderung von parasitären infektionen bei mensch und tier iii | |
| MY117535A (en) | Hiv protease inhibitors | |
| LT2002105A (en) | Novel use of siberian fir oil | |
| MX9706912A (es) | Inhibidores de protesa retroviral de sulfonamida de hidroxietilamino de amino acido y uso de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |